Safety and Efficacy of Chronic Hypnotic Use 2

Completed · Phase 4 · Has a placebo group

Conditions studied: Chronic Insomnia

In brief

This proposal will assess risks for transition from therapeutic hypnotic use to abuse in people with insomnia. The investigators will study a hypothesized at-risk sub-population, insomniacs with hyperarousal, and compare two hypnotics, a drug with mood effects, eszopiclone, versus one without mood effects, zolpidem.

Key facts

Study ID

NCT02456532

Run by

Henry Ford Health System

People needed

41

Starts

2015-08-05

Expected to finish

2022-02-22

Last updated by the study team

2024-03-29

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• DSM-5 diagnosis of insomnia

You may not qualify if…

• acute or unstable medical disease,
• current or past history of psychiatric disease, alcoholism or drug abuse, and other primary sleep disorders

Where it is running

• HFHS Sleep Disorders Ctr — Detroit, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.